A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Public ClinicalTrials.gov record NCT06764940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pivotal Phase II Clinical Trial of Utidelone Injection (UTD1) Plus Capecitabine (CAP) in HER2-negative Breast Cancer Patients With Brain Metastases
Study identification
- NCT ID
- NCT06764940
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biostar Pharma, Inc.
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Interventions
- Utidelone Drug
- Utidelone in combination with capecitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 13, 2025
- Primary completion
- Jan 14, 2027
- Completion
- Jul 14, 2027
- Last update posted
- Nov 27, 2025
2025 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope--Duarte | Duarte | California | 91010 | Not yet recruiting |
| Cancer & Blood Research Center, LLC | Los Alamitos | California | 90720 | Recruiting |
| Univ. of California Los Angeles | Los Angeles | California | 90095 | Not yet recruiting |
| FOMAT Medical Research (Network) | Oxnard | California | 93030 | Recruiting |
| Scripps Health | San Diego | California | 92121 | Recruiting |
| University Of Colorado Hospital - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | Recruiting |
| Biosresearch Partner | Hialeah | Florida | 33013 | Recruiting |
| D&H Cancer Research Center | Margate | Florida | 33063 | Recruiting |
| Augusta University | Augusta | Georgia | 30912 | Recruiting |
| Robert H. Lurie Comprehensive Cancer Center Northwestern University | Chicago | Illinois | 60611 | Recruiting |
| The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine | Baltimore | Maryland | 21287 | Not yet recruiting |
| Profound Research LLC | Farmington Hills | Michigan | 48334 | Recruiting |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | Recruiting |
| Stony Brook Cancer Center | Stony Brook | New York | 11794-7263 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Community Clinical Trials | Kingwood | Texas | 22751 | Recruiting |
| Tranquil Clinical Research | Webster | Texas | 77598 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06764940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2025 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06764940 live on ClinicalTrials.gov.